Showing results (2251-2260 of 2,301) with videos related to
Sort By:
Pageof 231
Frontiers in Cellular Neuroscience|January 2, 2023
Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence dataAhmad Al Khleifat, Alfredo Iacoangeli, Ashley R Jones, et al.Cancer Discovery|November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from HyperinsulinemiaAndreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.Nature Communications|November 13, 2022
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease durationSarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp, et al.The European Respiratory Journal|October 14, 2024
Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomicsNazanin Zounemat Kermani, Kian Fan Chung, Giuseppe Macis, et al.JAMA Neurology|June 1, 2016
Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral SclerosisIsabella Fogh, Kuang Lin, Cinzia Tiloca, et al.The European Respiratory Journal|November 5, 2021
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammationMaria Sparreman Mikus, Johan Kolmert, Lars I Andersson, et al.The Lancet. Diabetes & Endocrinology|February 26, 2021
Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settingsDianna J Magliano, Lei Chen, Rakibul M Islam, et al.Epilepsia|January 10, 2018
Defining the phenotypic spectrum of SLC6A1 mutationsKatrine M Johannesen, Elena Gardella, Tarja Linnankivi, et al.The Lancet. Neurology|March 31, 2018
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction modelHenk-Jan Westeneng, Thomas P A Debray, Anne E Visser, et al.The European Respiratory Journal|September 12, 2015
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohortDominick E Shaw, Ana R Sousa, Stephen J Fowler, et al.Pageof 231